Arrowhead Pharmaceuticals, Inc.

London & Capital Asset Management Ltd ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

10,700

Value ($000)

710

Weight

0.0%

2020 Q4 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	710	0.0%	10,700	12/31/2025
2025 Q3	11/12/2025	369	0.0%	10,700	9/30/2025
2024 Q4	2/14/2025	201	0.0%	10,700	12/31/2024
2024 Q3	11/14/2024	207	0.0%	10,700	9/30/2024
2024 Q2	8/14/2024	278	0.0%	10,700	6/30/2024
2024 Q1	5/15/2024	306	0.0%	10,700	3/31/2024
2023 Q4	1/30/2024	327	0.0%	10,700	12/31/2023
2023 Q3	11/15/2023	288	0.0%	10,700	9/30/2023
2023 Q2	8/14/2023	382	0.0%	10,700	6/30/2023
2023 Q1	5/15/2023	330	0.0%	13,000	3/31/2023
2022 Q4	2/14/2023	527	0.0%	13,000	12/31/2022
2022 Q3	11/29/2022	430	0.0%	13,000	9/30/2022
2022 Q2	8/15/2022	458	0.0%	13,000	6/30/2022
2022 Q1	5/16/2022	598	0.0%	13,000	3/31/2022
2021 Q4	2/14/2022	862	0.1%	13,000	12/31/2021
2021 Q3	11/15/2021	812	0.1%	13,000	9/30/2021
2021 Q2	8/16/2021	1,077	0.1%	13,000	6/30/2021
2021 Q1	5/14/2021	862	0.1%	13,000	3/31/2021
2020 Q4	2/16/2021	997	0.1%	13,000	12/31/2020